×
Back to Agenda
LS18 Global Oncology Development – 2nd
Session Chair(s)
Hironobu Saito, PHD
Corporate Advisor, Daiichi Sankyo Co., Ltd., Japan
Speaker(s)
Nobuyuki Hanamura, PHD, MBA
Senior Director, Clinical Operations, IQVIA, Japan
Tomohiro Nishina, MD, PHD
Director, Department of Cancer Genomic Medicine, National hospital Organization Shikoku Cancer Center, Japan
Kazuhiko Mori, PHD, MSC
Business Manager, "Toyama, the Silicon Valley of Medicine" Creative Consortium Management Office, Japan
Have an account?